Abstract The relatively recent discovery of miRNAs has added a completely new dimension to the study of the regulation of gene expression. The mechanism of action of miRNAs, the conservation between diverse species and the fact that each miRNA can regulate a number of targets and phenotypes clearly indicates the importance of these molecules. In this review the current state of knowledge relating to miRNA expression and gene regulation is presented, outlining the key morphological and biochemical features controlled by miRNAs with particular emphasis on the key phenotypes that impact on cell growth in bioreactors, namely proliferation and apoptosis.
Introduction
Research into the regulation of gene expression through the action of miRNAs has increased exponentially over the last 3 years as demonstrated by the fact that in 2003 there were less than 100 miRNA papers cited in the Pubmed database (http://www.pubmed.gov), and already there are greater than 500 cited for 2006 (December). The importance of miRNAs lies in the broad range of phenotypes they regulate including development (Ambros 2003; Chen et al. 2004) , cell proliferation and death (Brennecke et al. 2003) , apoptosis and fat metabolism (Xu et al. 2003) , cell differentiation (Chang et al. 2004 ) and a number of recent studies have identified miRNA profiles associated with diseases such as cancer ) and diabetes (Poy et al. 2004) hence it is clear that many of the phenotypes regulated by miRNAs are also of interest to the bioprocessing community. Currently there are modified CHO cell lines expressing genes to enhance apoptosis resistance (Crea et al. 2006; Choi et al. 2006; Kim et al. 2003; Ifandi and AlRubeai 2005; Meents et al. 2002) , CHO lines with engineered proliferation control (Fussenegger et al. 1997 Mazur et al. 1998 Mazur et al. , 1999 Ifandi and Al-Rubeai 2005; Bi et al. 2004; Carvalhal et al. 2003) and cells that have been engineered for improved metabolic phenotypes (Irani et al. 2002; Abston and Miller 2005) . In certain cases cells have been ''double engineered'' to achieve both apoptosis resistance and controlled proliferation Ifandi and AlRubeai 2005) , however over-engineering of cells has been linked to altered growth due to increased metabolic load (Yallop and Svendsen 2001; Yallop et al. 2003) . Unlike many single gene manipulations, most miRNAs can regulate a number of gene targets (Bartel 2004) , and the 3¢UTRs (untranslated regions) of many genes contain putative binding sites for a number of miRNAs. Individual miRNAs such as miR-21 have been found to regulate more than one phenoytype including apoptosis and proliferation (Chan et al. 2005; Cheng et al. 2005) . Currently there is no information on the expression of miRNAs in any hamster sub-types including Cricetulus griseus and none are listed in the Sanger miRNA repository of 4,361 known miRNAs. There are however a number of observations that implicate miRNAs in the regulation of CHO cell processes including the recent evidence that the cold shock protein Rbm3 increases global translation under conditions of mild hypothermia through inhibition of miRNA action (Dresios et al. 2005) . Reduction of the culture temperature is a commonly applied but poorly understood strategy to increase the productivity, viability and stationary phase duration of production cell lines (Al-Fageeh et al. 2006; Fogolin et al. 2004; Furukawa and Ohsuye 1998; Kaufmann et al. 1999) . miRNAs may also be responsible for the observed disconnects between microarray and proteomic CHO profiling data including the observation that although PDI, phosphoglycerate kinase and heat shock cognate 71 kDa protein were found upregulated upon reduction of culture temperature, the transcripts encoding these proteins were not significantly altered (Baik et al. 2006 ). More recently this laboratory has employed global miRNA profiling arrays to identify a number of differentially expressed miRNAs that correlate with both temperature and stage of suspension CHO culture (P. Gammell et al. in preparation) . This aim of this review is to identify miRNAs regulating useful and industrially relevant phenotypes and present the mechanism of action where known.
Background to miRNA biology
Lin-4 was identified as the first miRNA in a genetic screen for mutants that disrupt postembryonic development in Caenorhabditis elegans (Lee et al. 1993) . It was found upon cloning of the Lin-4 locus, that Lin-4 produced a 22 nt noncoding RNA rather than a protein and that this RNA repressed the expression of Lin-14, a nuclear protein involved in the development of worms (Lee et al. 1993; Wightman et al. 1993) . The action of Lin-4 required a high degree of homology between Lin-4 and sites in the 3¢ UTR of Lin-14 (Ha et al. 1996; Olsen and Ambros 1999) . In 2000 a second miRNA Let-7, was identified in C. elegans , which was demonstrated as having a similar function as Lin-4 (Reinhart et al. 2000; Slack et al. 2000; Lin et al. 2003) . As a result of these and subsequent discoveries, miRNAs have been identified as a major class of evolutionarily conserved, highly abundant regulatory molecules. Currently there are 4,361 entries in the Sanger miRBase database (Release 9.0 October 2006 http://www.microrna.sanger.ac.uk/sequences/). miRNAs are transcribed by RNA polymersase II as long primary miRNAs (pri-miRNAs) (Cai et al. 2004; Lee et al. 2004 ). The pri-miRNA is cleaved at its flanks by Drosha, a nuclear ribonuclease III (RNaseIII) endonuclease, yielding stem loop structure of about 70 nt termed the precursor miRNA (pre-miRNA) Denli et al. 2004; Gregory et al. 2004; Han et al. 2004 ). Pre-miRNAs have 5¢ phosphate and 3¢ hydroxy termini and 2-3 nt 3¢ single-stranded overhangs, these being characteristics of RNase III cleavage of dsRNA. Export of the pre-miRNA to the cytoplasm is facilitated by Exportin 5, which can recognize the specific end structure of miRNAs (Yi et al. 2003; Bohnsack et al. 2004; Lund et al. 2004; Zeng and Cullen 2004) . On reaching the cytoplasm, Dicer, also an RNase III endonuclease, liberates the miRNA duplex (~21 nt), and the mature miRNA strand of the miRNA duplex then enters the same RNAinduced silencing complex (RISC) that is also used for the siRNA directed silencing pathway (Hutvagner and Zamore 2002) . MiRNAs regulate target silencing using both target cleavage and translational repression. In plants it is more common to observe almost perfect homology between miRNA strands and the mRNA target, hence the RISC complex behaves as an endonuclease and cleaves the target mRNA between the target nucleotides paired to bases 10 and 11 of the miRNA. A number of mammalian miRNAs have also been demonstrated to cleave the target mRNAs also including miR-196 which can cleave HOXB8 mRNA in murine embryos and cell lines (Yekta et al. 2004 ). The normal situation for animal miRNAs however is that homology between the miRNA and the target mRNA is typically restricted to the 5¢ end of the miRNA (Lewis et al. 2003 (Lewis et al. , 2005 Brennecke et al. 2005) . In this situation, the bound miRNA-RISC complex inhibits translation of the target mRNA either at the level of translational elongation or initiation of translation (Olsen and Ambros 1999; Pillai et al. 2005) .
Despite the increasing number of identified and validated miRNA sequences currently available there is an almost complete lack of experimental evidence identifying the corresponding mRNA targets. A number of programs are available for the computational prediction of mRNA targets of miRNAs, however on average 200 genes, covering a range of gene categories are predicted to be regulated by each miRNA (reviewed by Krutzfeldt et al. 2006) , which is a continuing challenge for miRNA research.
MiRNAs regulating cell growth and proliferation
Many of the discoveries relating miRNA expression to function have come from single miRNA inactivation approaches. Naturally, due to the small size of miRNAs this has been technically challenging, however a number of antisensebased approaches are available that transiently block miRNA function (Meister et al. 2004) . A number of miRNAs regulating proliferation and growth have been identified through linkage with cancer phenotypes (reviewed by Esquela-Kershcer and Slack 2006), which is unsurprising as cancer is essentially a disease of uncontrolled proliferation.
Growth control in bioreactors is crucial for efficient protein production and the use of biphasic culture strategies to control growth are commonly employed whereby cells are initially grown in conditions to promote high proliferation rates to maximize viable biomass and subsequently cell division is arrested (typically through reduction of the culture temperature), to encourage productivity and reduce apoptosis (Reviewed in Al-Fageeh et al. 2006; Butler 2005) . A number of miRNAs have been identified that regulate the expression of proteins that control growth, including a number that have already been employed as targets for engineered proliferation control in CHO, these are presented here and summarized in Fig. 1 .
The miRNAs encoding Lin-4 and Let-7 are known to control the timing of proliferation and differentiation in C. elegans and mutations can lead to uncontrolled growth and abnormalities. Although these are neamatode miRNAs, the level of conservation in miRNAs is extremely high and the complete sequence of mature Let-7 is conserved from worms to humans . The mammalian homologues of these genes also control proliferation in murine and human cells, inhibition of the miR-125b (Lin-4 homologue) resulted in reduced proliferation of human cancer cells , whereas Let-7 has been found to be a potent growth suppressor when expressed in DLD-1 colon cancer and A549 lung adenocarcinoma cells (Takamizawa et al. 2004; Akao et al. 2006) . Let-7 represses RAS and C-MYC expression, and is greatly reduced in lung cancer facilitating high levels of RAS expression, hence it acts as a tumor suppressor in normal cells (Johnson et al. 2005; Akao et al. 2006) . CHO cell lines have been separately engineered to overexpress C-MYC and RAS resulting in cells with increased growth rates and enhanced CMV product expression, respectively (Ifandi and Al-Rubeai 2005; Katakura et al. 1999; Miura et al. 2001) . The use of C-MYC based approaches for the regulation of both proliferation and apoptosis is more complex than previously assumed following recent discoveries that although C-MYC induces the expression of the transcription factor E2F [essential for cell cycle progression and proliferation (Bracken et al. 2004) ], and the expression of miR-17-5p and miR-20a, both of which are components of the miR-17 cluster [associated with cell proliferation (Hayashita et al. 2005) ], miR-17-5p and miR-20a have been shown to negatively regulate E2F (O'Donnell et al. 2005 ). MiR-17-5p also inhibits the translation of amplified in breast cancer 1 (AIB1) resulting in reduced proliferation of breast cancer cell lines. The apparent tumor suppressor/growth enhancer effects of components of the miR-17 cluster seem to be dependant on both cell line and environment as the miR-17 cluster has also been linked to aggressive lymphomas and lung cancer, and has been shown to enhance lung cancer cell growth (Hayashita et al. 2005; He et al. 2005) . Therefore MYC and its associated miRNA and mRNA targets are all components of a feedback loop complex presumably designed for tight control of cell proliferation under normal circumstances.
Two related miRNAs miR-143 and miR-145 have been found to suppress growth in human cell lines in a mechanism that it is at least partly due to regulation of ERK5, a known target of miR-143 (Esau et al. 2004 ). Extracellular-signal-regulated kinase 5 (ERK5) is a member of the mitogenactivated protein kinase (MAPK) family and, similar to ERK1/2. ERK5 is activated by growth factors and has an important role in the regulation of cell proliferation (Nishimoto and Nishida 2006) . Other miRNAs that inhibit proliferation include miR-221 and miR-222 in CD34+ hematopoietic progenitor cells (HPCs), via downregulation of Kit protein (Felli et al. 2005) .
The use of cell cycle inhibitors in CHO cultures have been used to arrest growth as an alternative to mild hypothermia (Fusseneger et al. 1997; Bi et al. 2004; Mazur et al. 1999; Carvalhal et al. 2003) . A number of miRNAs regulate proliferation via direct interference with cell cycle control including miR-372 and miR-373 which promote proliferation in human cell lines in a manner insensitive to increased levels of the inhibitor p21 CIP1 essentially negating p53 mediated CDK inhibition (Voorhoeve et al. 2006) . Both p21 CIP1 and p27 KIP1 have been used to regulate growth in CHO with noticeable improvements in specific productivity (Bi et al. 2004; Mazur et al. 1998; Fussenegger et al. 1997 Meents et al. 2002; Kaufman et al. 2001) .
As an alternative to naturally occurring miRNAs, synthetic miRNA-like molecules can be generated against specific targets of choice. Transfection of specifically designed miRNAs against the 3¢ UTR of IGFBP-5 were able to both decrease proliferation and induce apoptosis in neuroblastoma cells (Tanno et al. 2005) .
Application of proliferation-related miRNAs to other cell types will require careful consideration as some of the effects can be cell line specific, i.e. the same miRNA may have very different effects depending on the cellular ? ?
miR-125b Fig. 1 Summary of miRNAs that regulate the expression of proteins that promote arrows or inhibit Tbars apoptosis and proliferation environment or context, in a specific example inhibition of miR-21 and miR-24 resulted in major increases in cell growth in HeLa but not A549 , and expression of miR-21 increased proliferation in glioblastoma cell lines (Chan et al. 2005) . It is likely that study of the tissue distribution profiles of miRNAs will help, i.e. ubiquitously expressed miRNAs having similar effects in many tissue types are likely to have similar effects when expressed in a range of cell lines, whereas tissue restricted miRNAs such as miR-133, the expression of which correlates with enhanced myoblast proliferation via repression of serum response factor (SRF), may be phenomenon associated with a particular tissue type, in this case skeletal muscle (Chen et al. 2006) .
miRNA targets regulating apoptosis
Apoptosis or programmed cell death (PCD) is an obstacle to maintaining the high viable cell densities required to ensure long-term productivity in bioreactors (reviewed by Laken and Leonard 2001) . Apoptosis in bioreactors is a result of a number of stressful conditions that emerge as a result of the production process, including nutrient limitation, mechanical agitation, oxygen depletion and waste accumulation (Al-Rubeai and Singh 1998). Cell death through apoptosis can have very negative effects on product quality and overall productivity Arden and Betenbaugh 2004) , therefore a number of apoptosis intervention approaches have been employed to extend the viable lifespan of mammalian cells in culture and hence increase overall productivity. Anti-apoptotic proteins including Bcl-2 and BclXl oppose the progression of apoptosis. These proteins inhibit apoptosis through the maintenance of mitochondrial membrane integrity and by binding to pro-apoptotic Bcl family members (Yang et al. 1997; Sun et al. 2002; Gross et al. 1999) . As a result of this, the exogenous expression of Bcl-2 and BclXl have formed the basis for a number of apoptosis intervention strategies in CHO, hybridoma and NS0 cells. In general most researchers have observed increased maximum cell number, enhanced viability, extended culture duration, protection from viral and sodium butyrate mediated apoptosis and in certain cases increased titers following expression of Bcl family members. (Fassnacht et al. 1999; Tey et al. 2000; Goswami et al. 1999; Simpson et al. 1999; Fussenegger et al. 2000; Mastrangelo et al. 2000a, b; Meents et al. 2002; Chiang and Sisk 2005; Kim and Lee 2002; Sung and Lee 2005; Sauerwald et al. 2006; Ifandi and Al-Rubeai 2005) . Viral homologues of Bcl-2 including E1B19K have also been used for the inhibition of apoptosis in mammalian cell cultures (Wong et al. 2006; Figueroa et al. 2006) , where E1B19K inhibits the apoptotic activity of p53 (Debbas and White 1993; Lowe and Ruley 1993) .
An early association of miRNAs with the regulation of with apoptosis came from a study of patients with chronic lymphotytic leukemia (CLL), in this study it was found that there was a correlation in the expression of Bcl-2 with the absence of miR-15 and miR-16 (Calin et al. 2002 (Calin et al. , 2004 . Subsequent cell line experiments confirmed that miR-15 and 16 promote apoptosis through negative regulation of Bcl-2 at a posttranslational level (Cimmino et al. 2005) .
Viruses also subvert the cell suicide pathways via miRNA action, and a recently discovered miRNA encoded within the HSV-1 LAT gene, exerts its anti-apoptotic function in mammalian cells via downregulation of TGF-b1 and SMAD3 (Gupta et al. 2006) . Regulation of TGF b1 translation can also be used to control cell growth as it is a potent growth inhibitor (Schuster and Krieglstein 2002) and experiments have shown that targeting the TGF b1 receptor in CHO cells can attenuate the growth inhibitory response to TGF b1 in wild-type CHO cells (Tseng et al. 2004) .
MiR-21 is known to be upregulated in a number of cancers and as such is described as an oncogenic miRNA (Si et al. 2006; Roldo et al. 2006; Meng et al. 2006; Volinia et al. 2006; Iorio et al. 2005; Chan et al. 2005 ) and operates at least partly via the inhibition of apoptosis. Silencing of miR-21 in glioblastoma cells was observed to result in activation of caspase 3 and 7 and increased apoptosis across a panel of cell lines and resulted in much lower proliferation rates (Chan et al. 2005) .
A number of other miRNAs have been implicated in the regulation of apoptosis including miR-278, de-regulated expression of this miRNA in Drospohila has been found to be responsible for massive overgrowth of developing eyes, through inhibition of apoptosis (Nairz et al. 2006 ) others include miR-1d, 7, 15, 16, 21, 148, 204, 210, 216, and 296 (Chan et al. 2005; Cheng et al. 2005) although the functional targets are unknown for most of these.
Conclusions and future prospects
The number of discoveries relating miRNA to cell growth and survival indicate that it will be important to relate these findings to industrially relevant cell lines including CHO. The improvements in the technology available to profile miRNA expression and the recent finding in this laboratory that these methods are suitable for use in CHO cultures (Gammell et al. in preparation) will accelerate this process.
